Skip to content
中文产业新闻精选评分58Chinese source

思璞锐与默沙东就口服KRAS G12D(ON)抑制剂SPR2015达成全球独家授权,首付款4亿美元

战火重燃!KRAS竞速赛,默沙东愿掏4亿美元首付款

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.